Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Santarpia M, Ramirez JL, de Aguirre I, Garrido P, Pérez Cano M, Queralt C, Gonzalez-Larriba JL, Insa A, Provencio M, Isla D, Camps C, Blanco R, Moran T, Rosell R; Spanish Lung Cancer Group. Santarpia M, et al. Clin Lung Cancer. 2017 Mar;18(2):178-188.e4. doi: 10.1016/j.cllc.2016.08.007. Epub 2016 Nov 9. Clin Lung Cancer. 2017. PMID: 27908619
Rare histotypes of epithelial biliary tract tumors: A literature review.
Sapuppo E, Brunetti O, Tessitore D, Brandi G, Di Giovanni N, Fadda G, Luchini C, Martini M, Quaresmini D, Russo A, Santarpia M, Scarpa A, Scartozzi M, Tuccari G, Franchina T, Silvestris N. Sapuppo E, et al. Among authors: santarpia m. Crit Rev Oncol Hematol. 2023 Jan;181:103892. doi: 10.1016/j.critrevonc.2022.103892. Epub 2022 Dec 5. Crit Rev Oncol Hematol. 2023. PMID: 36481306 Free article. Review.
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.
de las Peñas R, Sanchez-Ronco M, Alberola V, Taron M, Camps C, Garcia-Carbonero R, Massuti B, Queralt C, Botia M, Garcia-Gomez R, Isla D, Cobo M, Santarpia M, Cecere F, Mendez P, Sanchez JJ, Rosell R; Spanish Lung Cancer Group. de las Peñas R, et al. Among authors: santarpia m. Ann Oncol. 2006 Apr;17(4):668-75. doi: 10.1093/annonc/mdj135. Epub 2006 Jan 11. Ann Oncol. 2006. PMID: 16407418 Free article.
Applications of genomics in NSCLC.
Rosella R, Cobo M, Isla D, Miguel Sanchez J, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniza O. Rosella R, et al. Among authors: santarpia m. Lung Cancer. 2005 Dec;50S2:S33-S40. Lung Cancer. 2005. PMID: 16551521
Applications of genomics in NSCLC.
Rosell R, Cobo M, Isla D, Sanchez JM, Taron M, Altavilla G, Santarpia M, Moran T, Catot S, Etxaniz O. Rosell R, et al. Among authors: santarpia m. Lung Cancer. 2005 Dec;50 Suppl 2:S33-40. Lung Cancer. 2005. PMID: 16557672 Review.
Predicting the outcome of chemotherapy for lung cancer.
Rosell R, Cecere F, Santarpia M, Reguart N, Taron M. Rosell R, et al. Among authors: santarpia m. Curr Opin Pharmacol. 2006 Aug;6(4):323-31. doi: 10.1016/j.coph.2006.01.011. Epub 2006 Jun 12. Curr Opin Pharmacol. 2006. PMID: 16765644 Review.
Usefulness of predictive tests for cancer treatment.
Rosell R, Cuello M, Cecere F, Santarpia M, Reguart N, Felip E, Taron M. Rosell R, et al. Among authors: santarpia m. Bull Cancer. 2006 Aug;93(8):E101-8. Bull Cancer. 2006. PMID: 16935774 Free article. Review.
Emerging drugs for non-small-cell lung cancer.
Felip E, Santarpia M, Rosell R. Felip E, et al. Among authors: santarpia m. Expert Opin Emerg Drugs. 2007 Sep;12(3):449-60. doi: 10.1517/14728214.12.3.449. Expert Opin Emerg Drugs. 2007. PMID: 17874972 Review.
126 results